Robert Shumaker
ORCID：0000-0001-9962-8540
发表论文 74 篇 · 总被引 2589 次 · h-index 21
代表论文
- Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer (2020 · Journal of Clinical Oncology · 被引 531)
- Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial (2019 · The Lancet Oncology · 被引 482)
- Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors (2020 · Journal of Clinical Oncology · 被引 460)
- Population pharmacokinetic analysis of lenvatinib in healthy subjects and patients with cancer (2016 · British Journal of Clinical Pharmacology · 被引 76)
- Effect of Rifampicin on the Pharmacokinetics of Lenvatinib in Healthy Adults (2014 · Clinical Drug Investigation · 被引 76)
- Phase I Dose-Escalation Study of the Multikinase Inhibitor Lenvatinib in Patients with Advanced Solid Tumors and in an Expanded Cohort of Patients with Melanoma (2015 · Clinical Cancer Research · 被引 71)